Keywords: idec, non-hodgkin, lymphoma, antibody, clears, phase, iii

IDEC Non-Hodgkin's Lymphoma Antibody Clears Phase III Trials

Article | 16 December 1996

Print This

IDEC and Genentech have reported that their antibody treatment for non-Hodgkin's lymphoma, IDEC-C2B8, was found to be effective in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in